ICC 2026- 9th Edition of International Cancer Conference

Welcome To ICC 2026 | Tokyo, Japan

This conference is designed to attract a diverse audience, including distinguished scientists, clinical practitioners, industry leaders, and passionate advocates from the global cancer community. By bringing together a broad spectrum of professionals, ICC 2026 aims to facilitate meaningful dialogues and partnerships that advance our understanding and treatment of cancer.

Attendees will have the opportunity to engage with a wide range of topics that cover the multifaceted nature of cancer. The conference will address fundamental aspects such as the biology, causes, and types of cancer, alongside critical discussions on organ-specific cancers and the latest in imaging and diagnostic techniques. Furthermore, the event will explore the latest advancements in cancer treatment, including clinical trials, novel therapies, and the impact of emerging technologies like artificial intelligence. Key discussions will also cover cancer prevention strategies, the interplay between cancer and other diseases.

Participants can look forward to a series of presentations, interactive sessions, and workshops that will delve into the latest research findings, treatment innovations, and case studies. These sessions are crafted to foster deep learning and stimulate innovative thinking among all attendees.
In summary, ICC 2026 promises to be a transformative event in the oncology landscape. We look forward to welcoming you at ICC 2026, where we will collectively drive forward the frontiers of cancer research and treatment

General Scientific Sessions